-
RSV vaccine from GSK shows potential to protect adults 50 to 59
The results suggest that GSK’s shot could help protect a wider population from RSV, which causes thousands of hospitalizations and deaths each year.
-
As RSV cases tick up, CDC warns that a key drug to keep babies safe is in short supply
The Centers for Disease Control and Prevention alerted doctors nationwide Monday about a limited availability of certain doses of a newly approved antibody drug given to infants to prevent RSV infection.
-
RSV cases on the rise in Illinois as officials warn of possible ‘tripledemic'
As temperatures cool and more Illinois residents turn to indoor activities, officials say they are already beginning to see increases in RSV activity in the state.
-
New RSV protections for infants hit cost, insurance hurdles in U.S. rollout
Pfizer’s maternal vaccine, Abrysvo, and Sanofi’s monoclonal antibody, Beyfortus, were approved for expectant mothers and infants in the U.S. earlier this year.
-
CDC recommends Pfizer maternal RSV vaccine to protect infants, paving way for fall availability
The CDC specifically recommended that expectant mothers 32 to 36 weeks into their pregnancy receive the shot, Pfizer’s Abrysvo, from September through January.
-
CDC alerts doctors to an increase in RSV cases among young children and babies
The Centers for Disease Control and Prevention alerted doctors Tuesday about a rise in severe cases of RSV among young children in Florida and Georgia.
-
Sanofi expects infant RSV shot to roll out before respiratory virus season this fall
Sanofi said it is working with a CDC panel to include Beyfortus on the childhood immunization schedule and the Vaccines for Children Program.
-
New drug to protect babies, toddlers from RSV gets approval
A new treatment to protect young Americans from RSV has received FDA approval, with cold and flu season waiting in the wings. NBC 5 Health and Wellness Reporter Lauren Petty has more details.
-
New drug to protect babies and toddlers from RSV gets FDA approval ahead of cold season
U.S. officials on Monday approved the first long-acting drug to protect babies and toddlers against a respiratory virus that sends tens of thousands of American children to the hospital each year.
-
Older Americans can get RSV vaccine this fall after consulting their doctor, CDC says
Americans 60 and older can get a new RSV vaccine but should discuss it with their doctor first.
-
FDA Advisers Back RSV Vaccine for Pregnant Women That Protects Their Newborns
A first-of-its-kind RSV vaccine for pregnant women guards their newborns against the scary respiratory virus -– and federal health advisers on Thursday backed Pfizer’s shot despite some lingering questions.
-
FDA Approves RSV Vaccines for Adults 60 and Up
The Food and Drug Administration has a approved the first RSV vaccine for adults 60 and older